Is Thymosin Alpha-1 safe?
Emerging ResearchSide effects, risks, and safety considerations based on available research.
Research status
Thymosin Alpha-1 has some clinical data but research is still developing. Safety data exists but may come from small studies, short-term trials, or specific populations that may not reflect your situation.
Known concerns & side effects
- ⚠not FDA-approved in the United States
- ⚠most robust evidence is for hepatitis and cancer adjunct therapy, not general wellness
- ⚠immune stimulation could theoretically worsen autoimmune conditions
- ⚠unregulated US supply chain — pharmaceutical-grade versions differ from research peptides
- ⚠injection-based administration carries infection risk
Use caution with
Frequently asked questions
Is Thymosin Alpha-1 approved anywhere?
Yes. It is approved in over 30 countries (as Zadaxin) for hepatitis B treatment and as an immune adjuvant. It is not FDA-approved in the United States, though it is used off-label by some physicians.
Can Thymosin Alpha-1 help with autoimmune conditions?
This is complicated. Thymosin Alpha-1 modulates the immune system rather than simply boosting it, which means it could theoretically help rebalance dysregulated immunity. However, stimulating immune activity in someone with active autoimmune disease could worsen symptoms. Use in autoimmune conditions should only be considered under close physician supervision.
Full Thymosin Alpha-1 Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2025-03-21
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.